[Burkitt's tumor: etiology, clinic and therapy (author's transl)].
D000293:Adolescent; D000328:Adult; D000350:Africa, Central; D002051:Burkitt Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000601:surgery / Q000628:therapy; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D005260:Female; D004854:Herpesvirus 4, Human / Q000032:analysis; D006801:Humans; D008297:Male; D008339:Mandibular Neoplasms / Q000175:diagnosis; D008441:Maxillary Neoplasms / Q000175:diagnosis; D008727:Methotrexate / Q000627:therapeutic use; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use
D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate
Burkitt-Lymphom: Atiologie, Klinik und Therapie